Beta-Blocker Use and 30-Day All-Cause Readmission in Medicare Beneficiaries with Systolic Heart Failure

BACKGROUND: Beta-blockers improve outcomes in patients with systolic heart failure. However, it is unknown whether their initial negative inotropic effect may increase 30-day all-cause readmission, a target outcome for Medicare cost reduction and financial penalty for hospitals under the Affordable...

Full description

Saved in:
Bibliographic Details
Published in:Am J Med
Main Authors: Bhatia, Vikas, Bajaj, Navkaranbir S., Sanam, Kumar, Hashim, Taimoor, Morgan, Charity J., Prabhu, Sumanth D., Fonarow, Gregg C., Deedwania, Prakash, Butler, Javed, Carson, Peter, Love, Thomas E., Kheirbek, Raya, Aronow, Wilbert S., Anker, Stefan D., Waagstein, Finn, Fletcher, Ross, Allman, Richard M., Ahmed, Ali
Format: Artigo
Language:Inglês
Published: 2014
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6756434/
https://ncbi.nlm.nih.gov/pubmed/25554369
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.amjmed.2014.11.036
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items